BIBN4096BS is a potent competitive antagonist of the relaxant effects of α-CGRP on human temporal artery: comparison with CGRP(8-37)-Reference-Cited by-同舟云学术

BIBN4096BS is a potent competitive antagonist of the relaxant effects of α-CGRP on human temporal artery: comparison with CGRP(8-37)

Published:2002-05 Issue:1 Volume:136 Page:120-126
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Verheggen Raphaela,Bumann Katja,Kaumann Alberto J.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0704682/fullpdf

Reference32 articles.

1. Some quantitative uses of drug antagonists;ARUNLAKSHANA;Br. J. Pharmacol.,1959

2. Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets;BÖHME;Advances Cyclic Nucleotide Research,1978

3. Inhibitors and activators of cyclic nucleotide phosphodiesterases;CHASIN;Advances Cyclic Nucleotide Research,1976

4. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37);CHIBA;Am. J. Physiol.,1989

5. Effect of papaverine on cyclic nucleotide levels in the isolated rat aorta;DEMESY-WAELDELE;Eur. J. Pharmacol.,1977

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pharmacological Review of Calcitonin Gene-Related Peptide Biologics and Future Use for Chronic Pain;Cureus;2023-02-17

2. Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation;Frontiers in Pharmacology;2022-12-08

3. Novel synthetic treatment options for migraine;Expert Opinion on Pharmacotherapy;2020-12-28

4. Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials;Frontiers in Pharmacology;2020-01-24

5. Evaluation of Cardiovascular Outcomes in Adult Patients With Episodic or Chronic Migraine Treated With Galcanezumab: Data From Three Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1, EVOLVE‐2, and REGAIN Studies;Headache: The Journal of Head and Face Pain;2019-11-13